Article
P2X7 receptor-deficient mice are susceptible to bone cancer pain.
Pain - 1 Aug 2011
Hansen Rikke Rie, Nielsen Christian K, Nasser Arafat, Thomsen Stine I M, Eghorn Laura F, Pham Yen, Schulenburg Cecilia, Syberg Susanne, Ding Ming, Stojilkovic Stanko S, Jorgensen Niklas R, Heegaard Anne-Marie
Abstract excerpt
The purinergic P2X7 receptor is implicated in both neuropathic and inflammatory pain, and has been suggested as a possible target in pain treatment. However, the specific role of the P2X7 receptor in bone cancer pain is unknown. We demonstrated that BALB/cJ P2X7 receptor knockout (P2X7R KO) mice were susceptible to bone cancer pain and moreover had an earlier onset of pain-related behaviours compared with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
